FEops Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 31
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $545K
Latest Deal Amount
  • Investors
  • 9

FEops General Information

Description

Developer of personalized computer modelling technologies designed to improve transcatheter valve procedures and structural heart interventions. The company's proprietary array of products use advanced computer simulations to provide clinicians and valve manufacturers with first-ever insights into the interaction between the valve and specific patient anatomy - preoperatively, enabling cardiologists and cardiovascular surgeons to accelerate research and development of novel valve-based technologies and ultimately improve clinical outcomes in real-world hospital settings.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Surgical Devices
Primary Office
  • Technologiepark 122
  • 9052 Gent
  • Belgium
+32 09 000 00 00

FEops Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FEops Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 16-Apr-2020 $545K 00.000 Completed Generating Revenue
6. Accelerator/Incubator 10-Dec-2019 00.00 00.000 Completed Generating Revenue
5. Accelerator/Incubator 23-Sep-2019 00.000 Completed Generating Revenue
4. Grant 12-Nov-2018 00.000 00.000 Completed Generating Revenue
3. Later Stage VC (Series B) 22-Sep-2017 00.000 00.000 Completed Generating Revenue
2. Grant 20-Jan-2016 $54.5K $1.68M Completed Generating Revenue
1. Early Stage VC (Series A) 19-Dec-2014 $1.68M $1.68M 00.000 Completed Generating Revenue
To view FEops’s complete valuation and funding history, request access »

FEops Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B 00,000 000.0 000.0 00 000.0 00.000
Class B 0,000 000.00 000.00 00 000.00 0.000
Preference 4,845 $19.97 $19.97 1x $19.97 2.86%
To view FEops’s complete cap table history, request access »

FEops Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of personalized computer modelling technologies designed to improve transcatheter valve procedures and structu
Other Healthcare Technology Systems
Gent, Belgium
31 As of 2019
00.000
0000000000 00.000

00000000

uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
00000000 0000000
Los Angeles, CA
00 As of 0000
000.00
000000000 - 000.00

00000000

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mol
0000000000 000000000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FEops Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Surgical Theater Venture Capital-Backed Los Angeles, CA 00 000.00 000000000 - 000.00
0000000000 Venture Capital-Backed 000.00 00000000000 000.00
00000 0000000 Formerly VC-backed London, United Kingdom 000 00000 000000&0 00000
000000000 Venture Capital-Backed Santa Clara, CA 00 000.00 000000000 - 000.00
To view FEops’s complete competitors history, request access »

FEops Executive Team (7)

Name Title Board Seat Contact Info
Matthieu De Beule Ph.D Co-Founder, Chief Executive Officer & Board Member
Isabelle Decroos Chief Financial Officer
Peter Mortier Ph.D Co-Founder, Chief Technology Officer & Board Member
Nico Uwents Director, Business Development
Benedict Verhegghe Ph.D Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

FEops Board Members (8)

Name Representing Role Since
Jose Gordo Self Board Member 000 0000
Kenneth Wils PMV Board Member 000 0000
Marc Lambrechts Ph.D Capricorn Partners Board Member 000 0000
Matthieu De Beule Ph.D FEops Co-Founder, Chief Executive Officer & Board Member 000 0000
Peter Mortier Ph.D FEops Co-Founder, Chief Technology Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

FEops Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FEops Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vlaams Agentschap Innoveren en Ondernemen Endowment Limited Partner 000 0000 000000 0
European Commission Government 000 0000 000000 0
3DEXPERIENCE Lab Accelerator/Incubator Minority 000 0000 000000 0
ITEA 3 Corporation 000 0000 000000 0
Personalised In-silico Cardiology Corporation 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »